KILITCH DRUGS INDIA LTD

KILITCH

Small Cap | Pharmaceuticals
358.45
-10.54 (-2.85%)

Stock price as on 06 Feb 2026 at 15:30 PM

Kilitch drugs india ltd share price update

As of the latest trading session, Kilitch Drugs India Ltd share price is currently at ₹358.45, which is down by ₹-10.54 from its previous closing. Tod...

Kilitch Drugs India Ltd stock performance

Today’s low

₹357.4

Today’s high

₹374

₹358.45

52 week low

₹293.53

52 week high

₹500

₹358.45
Open
₹372.00
Previous close
₹369.00
Share volume
18,877
Total traded value (Lakh)
₹67.66
Upper circuit
₹442.80
Lower circuit
₹295.20

Kilitch Drugs India Ltd fundamentals

Market cap (Cr)
₹626.60
P/E ratio (TTM)
19.59
Book value per share
₹180.73
Beta
0.83
Return on equity
11.02%
Earnings per share (TTM)
₹18.17
Dividend yield
0%
Net profit/quarter (Cr)
₹8.72

Kilitch Drugs India Ltd financials

(Values in Cr)
Revenue
Net income

Particulars

Sep 25 (₹ value in crores)

Revenue

₹37.81

Operating expense

₹35.35

Net income

₹8.72

Net profit margin

23.06%

Earning per share

₹5.27

EBITDA

₹11.28

Effective tax rate

13.5%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹34.12

Operating expense

₹31.64

Net income

₹4.79

Net profit margin

14.03%

Earning per share

₹2.98

EBITDA

₹7.07

Effective tax rate

19.89%

Particulars

Mar 25 (₹ value in crores)

Revenue

₹56.30

Operating expense

₹43.62

Net income

₹11.37

Net profit margin

20.19%

Earning per share

₹7.07

EBITDA

₹16.23

Effective tax rate

24.13%

Particulars

Dec 24 (₹ value in crores)

Revenue

₹46.51

Operating expense

₹39.36

Net income

₹6.88

Net profit margin

14.79%

Earning per share

₹4.28

EBITDA

₹10.48

Effective tax rate

27.73%

Particulars

Sep 24 (₹ value in crores)

Revenue

₹45.35

Operating expense

₹40.58

Net income

₹8.85

Net profit margin

19.51%

Earning per share

₹5.50

EBITDA

₹11.40

Effective tax rate

16.35%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹181.59

Operating expense

₹154.62

Net income

₹31.16

Net profit margin

17.15%

Earning per share

₹19.37

EBITDA

₹44.56

Effective tax rate

23.42%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹131.60

Operating expense

₹114.44

Net income

₹17.57

Net profit margin

13.35%

Earning per share

₹11.03

EBITDA

₹26.50

Effective tax rate

24.75%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹117.78

Operating expense

₹102.94

Net income

₹15.72

Net profit margin

13.34%

Earning per share

₹10.09

EBITDA

₹21.77

Effective tax rate

19.17%

Particulars

Mar 22 (₹ value in crores)

Revenue

₹105.16

Operating expense

₹95.78

Net income

₹10.53

Net profit margin

10.01%

Earning per share

₹6.76

EBITDA

₹15.55

Effective tax rate

24.4%

Particulars

Mar 21 (₹ value in crores)

Revenue

₹70.02

Operating expense

₹66.70

Net income

₹6.16

Net profit margin

8.79%

Earning per share

₹3.98

EBITDA

₹9.40

Effective tax rate

17.97%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹125.81

Return on Equity (ROE)

11.68%

Return on Capital Employed (ROCE)

15.57%

Total debt to equity ratio

0.21

EBITDA margin

19.63%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹109.62

Return on Equity (ROE)

8.28%

Return on Capital Employed (ROCE)

13.3%

Total debt to equity ratio

0.16

EBITDA margin

18.62%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹94.08

Return on Equity (ROE)

5.7%

Return on Capital Employed (ROCE)

10.24%

Total debt to equity ratio

0.15

EBITDA margin

14.79%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹89.26

Return on Equity (ROE)

4.03%

Return on Capital Employed (ROCE)

6.34%

Total debt to equity ratio

0.13

EBITDA margin

10.55%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹82.05

Return on Equity (ROE)

2.41%

Return on Capital Employed (ROCE)

3.51%

Total debt to equity ratio

0.11

EBITDA margin

9.9%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹157.28

Return on Equity (ROE)

11.02%

Return on Capital Employed (ROCE)

13.14%

Total debt to equity ratio

0.17

EBITDA margin

21.1%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹138.61

Return on Equity (ROE)

8.39%

Return on Capital Employed (ROCE)

10.74%

Total debt to equity ratio

0.13

EBITDA margin

20.23%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹122.53

Return on Equity (ROE)

8.41%

Return on Capital Employed (ROCE)

9.89%

Total debt to equity ratio

0.11

EBITDA margin

18.63%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹112.65

Return on Equity (ROE)

6.18%

Return on Capital Employed (ROCE)

7.82%

Total debt to equity ratio

0.1

EBITDA margin

14.92%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹105.16

Return on Equity (ROE)

3.32%

Return on Capital Employed (ROCE)

4.2%

Total debt to equity ratio

0.09

EBITDA margin

11.9%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹9.84

Total assets

₹312.78

Total liabilities

₹312.78

Total equity

₹200.45

Shares outstanding

₹1.60

Price to book ratio

₹2.30

Return on assets (%)

8.53%

Return on capital

10.69%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹19.64

Total assets

₹240.06

Total liabilities

₹240.06

Total equity

₹175.67

Shares outstanding

₹1.60

Price to book ratio

₹2.81

Return on assets (%)

6.08%

Return on capital

7.04%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹19.97

Total assets

₹219.52

Total liabilities

₹219.52

Total equity

₹150.57

Shares outstanding

₹1.55

Price to book ratio

₹1.14

Return on assets (%)

4.75%

Return on capital

6.05%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹10.06

Total assets

₹209.84

Total liabilities

₹209.84

Total equity

₹140.29

Shares outstanding

₹1.55

Price to book ratio

₹1.49

Return on assets (%)

3.51%

Return on capital

4.58%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹12.50

Total assets

₹203.17

Total liabilities

₹203.17

Total equity

₹129.47

Shares outstanding

₹1.54

Price to book ratio

₹0.77

Return on assets (%)

1.85%

Return on capital

2.61%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹7.45

Total assets

₹358.15

Total liabilities

₹358.15

Total equity

₹252.94

Shares outstanding

₹1.60

Price to book ratio

₹2.30

Return on assets (%)

8.69%

Return on capital

10.32%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹18.62

Total assets

₹287.47

Total liabilities

₹287.47

Total equity

₹222.92

Shares outstanding

₹1.60

Price to book ratio

₹2.81

Return on assets (%)

6.11%

Return on capital

6.91%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹17.96

Total assets

₹252.41

Total liabilities

₹252.41

Total equity

₹195.93

Shares outstanding

₹1.55

Price to book ratio

₹1.14

Return on assets (%)

6.22%

Return on capital

7.22%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹2.44

Total assets

₹232.29

Total liabilities

₹232.29

Total equity

₹178.03

Shares outstanding

₹1.55

Price to book ratio

₹1.49

Return on assets (%)

4.53%

Return on capital

5.31%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹5.77

Total assets

₹195.84

Total liabilities

₹195.84

Total equity

₹162.93

Shares outstanding

₹1.54

Price to book ratio

₹0.77

Return on assets (%)

3.14%

Return on capital

3.47%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹34.47

Cash from operations

₹26.01

Cash from investing

-₹39.94

Cash from financing

₹13.24

Net change in cash

-₹9.16

Free cash flow

₹72.88

Particulars

Mar 24 (₹ value in crores)

Net income

₹19.35

Cash from operations

₹5.50

Cash from investing

-₹8.15

Cash from financing

₹8.80

Net change in cash

-₹0.88

Free cash flow

₹11.95

Particulars

Mar 23 (₹ value in crores)

Net income

₹12.01

Cash from operations

₹6.91

Cash from investing

₹7.91

Cash from financing

-₹0.71

Net change in cash

₹9.78

Free cash flow

₹10.72

Particulars

Mar 22 (₹ value in crores)

Net income

₹9.61

Cash from operations

₹8.31

Cash from investing

-₹15.25

Cash from financing

₹7.02

Net change in cash

-₹2.43

Free cash flow

₹16.52

Particulars

Mar 21 (₹ value in crores)

Net income

₹5.11

Cash from operations

₹46.67

Cash from investing

-₹37.56

Cash from financing

₹1.61

Net change in cash

₹9.70

Free cash flow

₹82.96

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹40.68

Cash from operations

₹23.70

Cash from investing

-₹41.42

Cash from financing

₹15.65

Net change in cash

-₹10.54

Free cash flow

₹70.57

Particulars

Mar 24 (₹ value in crores)

Net income

₹23.35

Cash from operations

₹4.45

Cash from investing

-₹8.70

Cash from financing

₹11.40

Net change in cash

₹0.11

Free cash flow

₹10.97

Particulars

Mar 23 (₹ value in crores)

Net income

₹19.44

Cash from operations

₹10.42

Cash from investing

₹6.24

Cash from financing

₹3.04

Net change in cash

₹15.38

Free cash flow

₹13.97

Particulars

Mar 22 (₹ value in crores)

Net income

₹13.92

Cash from operations

₹7.74

Cash from investing

-₹16.08

Cash from financing

₹7.55

Net change in cash

-₹3.32

Free cash flow

₹15.94

Particulars

Mar 21 (₹ value in crores)

Net income

₹7.50

Cash from operations

₹7.13

Cash from investing

-₹5.34

Cash from financing

₹2.27

Net change in cash

₹3.05

Free cash flow

₹7.55

Kilitch Drugs India Ltd technical summary

₹358.45
-2.85 ▼
14
Bearish
2
Bullish
5 Day349.2
10 Day340.3
12 Day338.7
20 Day336.7
26 Day337
50 Day341.6
100 Day352.5
200 Day361.3
5 Day347
10 Day332.5
12 Day329.9
20 Day331.9
26 Day336.5
50 Day338.8
100 Day351.5
200 Day383.8

380.1

PIVOT

First support
₹354.20
First resistance
₹394.90
Second support
₹339.40
Second resistance
₹420.80
Third support
₹313.50
Third resistance
₹435.60
RSI
61.87
ADX
15.34
MACD
1.73
Williams % R
-48.82
Commodity Channel Index (CCI)
157.04
Date
06 Feb 2026
Same day
11,464
Week
13,764
Month
8,431
1 year
0.83
3 years
0.68
Over 1 month
1.91%
Over 1 year
14.71%
Over 3 months
-4.92%
Over 3 years
35.34%
Over 6 months
-19.08%
Over 6 years
32.76%

Investment Returns

Over 1 Month1.91%
Over 3 Months4.92%
Over 6 Months19.08%
Over 1 Year14.71%

Kilitch Drugs India Ltd Shareholding pattern


Public
36.22%
Promoter holdings
63.77%
FII
0%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Kilitch Company (pharma) Limited

66,29,342 (37.92%)

Shareholding of Promoter and Promoter Group

Bhavin Mukund Mehta

25,23,138 (14.43%)

Shareholding of Promoter and Promoter Group

Mukund Mehta

11,54,647 (6.61%)

Shareholding of Promoter and Promoter Group

Mira Bhavin Mehta

8,41,046 (4.81%)

Shareholding of Promoter and Promoter Group

Dipak Kanayalal Shah

6,36,250 (3.64%)

Public Shareholding

Promoter sharesShareCategory
Kilitch Company (pharma) Limited66,29,342 (37.92%)Shareholding of Promoter and Promoter Group
Bhavin Mukund Mehta25,23,138 (14.43%)Shareholding of Promoter and Promoter Group
Mukund Mehta11,54,647 (6.61%)Shareholding of Promoter and Promoter Group
Mira Bhavin Mehta8,41,046 (4.81%)Shareholding of Promoter and Promoter Group
Dipak Kanayalal Shah6,36,250 (3.64%)Public Shareholding
Mukul Mahavir Agrawal2,35,000 (1.34%)Public Shareholding
Premilaben Rameshchandra Shah2,00,000 (1.14%)Public Shareholding

About KILITCH DRUGS INDIA LTD

Kilitch Drugs (India) Limited (KDIL), incorporated in May, 1992 is the one of the leading and fastest growing pharmaceutical companies in the world, manufacturing, supplying and marketing broad range of pharmaceutical formulations in the various dosage forms like Solid, Liquid and Parental across the globe. Their extensive research efforts have led to development of comprehensive, diverse and highly complementary portfolio of medicines targeting a wide spectrum of chronic and acute treatments which includes Sterile dosages namely Injectables &

Parent Organisation

Indian Private

NSE Symbol

KILITCH

Founded

1992

KILITCH DRUGS INDIA LTD CORPORATE ACTION

Dividend dateDividend amountDividend typeRecord dateInstrument type
20 Sept 20190.5Final24 Sept 2019Equity shares
18 Sept 20180.5Final20 Sept 2018Equity shares
24 Sept 201230Special25 Sept 2012Equity shares
18 Aug 20111Final23 Aug 2011Equity shares
14 Oct 20101Final15 Oct 2010Equity shares
10 Sept 20091Final12 Sept 2009Equity shares
10 Sept 20081Final12 Sept 2008Equity shares
15 Nov 20071Interim16 Nov 2007Equity shares

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)